Companies › GNTA

GENENTA SCIENCE S P A (GNTA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001838716 · EDGAR filings · Updated 2026-07-14

GENENTA SCIENCE S P A (GNTA) has reported institutional ownership of 4.4%, with 11 institutional managers holding positions valued at $695.7K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-14 — Foreign issuer report (6-K) filed
• 2026-07-01 — Foreign issuer report (6-K) filed
• 2026-06-26 — Foreign issuer report (6-K) filed
• 2026-06-24 — Foreign issuer report (6-K) filed
• 2026-06-17 — Foreign issuer report (6-K) filed
• 2026-06-16 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, GENENTA SCIENCE S P A has 11 institutional holders and institutional ownership of 4.4%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 6 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

Cocrystal Pharma Inc (COCP) · ERNEXA THERAPEUTICS INC (ERNA) · INTELLIGENT BIO SOLUTIONS IN (INBS) · BONE BIOLOGICS CORP (BBLG) · Exicure Inc (XCUR) · P3 HEALTH PARTNERS INC (PIII)